(Q251347)

reactant

1 reference

Gene Ontology release 2019-11-16

cellular response to haloperidol

reactant

1 reference

Gene Ontology release 2019-11-16

has use

medication

0 references

chemical structure

Haloperidol.svg
512 × 330; 4 KB

1 reference

imported from Wikimedia project

German Wikipedia

mass

375.140135 dalton

1 reference

haloperidol (English)

3 October 2016

chemical formula

C₂₁H₂₃ClFNO₂

1 reference

haloperidol (English)

19 November 2016

canonical SMILES

C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F

1 reference

haloperidol (English)

19 November 2016

defined daily dose

8 milligram

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05AD01

8 milligram

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05AD01

3.3 milligram

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=N05AD01

1 reference

14 February 2018

World Health Organisation international non-proprietary name

haloperidol (English)

1 reference

medical condition treated

Recommended INN: List 4

schizophreniform disorder

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

2 October 2018

schizoaffective disorder

1 reference

2 October 2018

mental disorder

1 reference

2 October 2018

anxiety

1 reference

significant drug interaction

2 October 2018

delirium

0 references

amiodarone

1 reference

High-priority drug–drug interactions for use in electronic health records

anagrelide

1 reference

High-priority drug–drug interactions for use in electronic health records

arsenic trioxide

1 reference

High-priority drug–drug interactions for use in electronic health records

astemizole

1 reference

High-priority drug–drug interactions for use in electronic health records

azithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

bepridil

1 reference

High-priority drug–drug interactions for use in electronic health records

chloroquine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

cisapride

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-citalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

clarithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

cocaine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

dofetilide

1 reference

High-priority drug–drug interactions for use in electronic health records

domperidone

1 reference

High-priority drug–drug interactions for use in electronic health records

dronedarone

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

escitalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

flecainide

1 reference

High-priority drug–drug interactions for use in electronic health records

halofantrine

1 reference

High-priority drug–drug interactions for use in electronic health records

ibutilide

1 reference

High-priority drug–drug interactions for use in electronic health records

mesoridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

moxifloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

ondansetron

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

pimozide

1 reference

High-priority drug–drug interactions for use in electronic health records

probucol

1 reference

High-priority drug–drug interactions for use in electronic health records

procainamide

1 reference

High-priority drug–drug interactions for use in electronic health records

quinidine

1 reference

High-priority drug–drug interactions for use in electronic health records

sevoflurane

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

sparfloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

terfenadine

1 reference

High-priority drug–drug interactions for use in electronic health records

thioridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ondansetron

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anagrelide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pasireotide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vandetanib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

domperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fingolimod

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toremifene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tetrabenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ivabradine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bromocriptine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(−)-selegiline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

methyldopa

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cabergoline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levodopa

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toremifene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ivabradine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vandetanib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

extrapyramidal symptoms

1 reference

A reference set of clinically relevant adverse drug-drug interactions

encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dyskinesia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

asthenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

brain injury

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

propranolol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

cogwheel rigidity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

gait abnormality

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

5-hydroxytryptamine receptor 1A

1 reference

5-hydroxytryptamine receptor 1D

17 August 2016

1 reference

5-hydroxytryptamine receptor 2A

17 August 2016

2 references

17 August 2016

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL54

5-hydroxytryptamine receptor 2B

1 reference

5-hydroxytryptamine (serotonin) receptor 7

17 August 2016

1 reference

5-hydroxytryptamine receptor 7

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

1 reference

17 August 2016

Histamine receptor H1

1 reference

Potassium inwardly-rectifying channel, subfamily J, member 6

17 August 2016

1 reference

Potassium voltage-gated channel subfamily H member 1

17 August 2016

1 reference

17 August 2016

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL54

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL54

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

Australian pregnancy category C

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category B

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Haloperidol

25 March 2018

1 reference

2 references

5 March 2018

15 March 2018

1 reference

15 March 2018

1 reference

MeSH descriptor ID

D006220

15 March 2018

anti-dyskinesia agents

1 reference

MeSH descriptor ID

D006220

female reproductive toxicant

15 March 2018

start time

29 January 1999

1 reference

California Proposition 65 list of chemicals

26 February 2020

https://oehha.ca.gov/chemicals/haloperidol

developmental toxicant

start time

29 January 1999

1 reference

California Proposition 65 list of chemicals

26 February 2020

https://oehha.ca.gov/chemicals/haloperidol

essential medicine

0 references

MCN code

2933.39.15

0 references

0 references

0 references

0 references

0 references

0 references

Haloperidol

0 references

Identifiers

InChI

InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2

1 reference

haloperidol (English)

19 November 2016

2 references

haloperidol (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

52-86-8

2 references

https://commonchemistry.cas.org/detail?cas_rn=52-86-8

haloperidol (English)

19 November 2016

7 April 2021

1 reference

haloperidol (English)

19 November 2016

2 references

haloperidol (English)

19 November 2016

Reaxys registry number

331267

1 reference

haloperidol (English)

3 October 2016

ChEBI ID

5613

mapping relation type

2 references

HALOPERIDOL (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2

1 reference

HALOPERIDOL (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU112201

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU112202

0 references

MSBNK-Athens_Univ-AU112203

0 references

MSBNK-Athens_Univ-AU112204

0 references

MSBNK-Athens_Univ-AU112205

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA002247

0 references

MSBNK-Waters-WA002248

0 references

MSBNK-Waters-WA002249

0 references

MSBNK-Waters-WA002250

0 references

MSBNK-Waters-WA002251

0 references

SPLASH

splash10-00or-0409000000-d542c35143556b83b87a

0 references

splash10-014i-0900000000-3985dded029c89448ebe

0 references

splash10-01b9-0900000000-720c0a4f1130b4237f32

0 references

splash10-00di-0900000000-772a799ebb3b949cef0c

0 references

splash10-004i-0009000000-21c8918254235e561129

0 references

splash10-014i-0904000000-8c97cb39f9680dd91378

0 references

splash10-01b9-0900000000-571a03ebb5faa3e5cd63

0 references

splash10-00di-0900000000-62e233fd691121c78e96

0 references

splash10-00di-0900000000-91bf80d34ef94ed709f0

0 references

splash10-00di-0900000000-46ef29917220709863a4

0 references

splash10-00di-3900000000-26f391756d439f7dbfc8

0 references

splash10-00b9-9600000000-404fc399b40cfb560a99

0 references

splash10-00b9-9100000000-8779758823471091566a

0 references

splash10-004i-1619000000-27aa28ad7f91429f5ae7

0 references

splash10-0079-3290000000-cc6a990404ba7b9452a8

0 references

NMRShiftDB structure ID

20207509

1 reference

HSDB ID

3093

1 reference

Hazardous Substances Data Bank

28 October 2019

HALOPERIDOL (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

0 references

1 reference

haloperidol (English)

ECHA Substance Infocard ID

19 November 2016

100.000.142

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.000.142

27 December 2018

Haloperidol (English)

quotation

CAS no.: 52-86-8 (English)

0 references

1 reference

World Health Organisation international non-proprietary name numeric ID

Haloperidol (English)

publication date

17 November 2015

918

0 references

1 reference

haloperidol (English)

19 November 2016

Haloperidol

0 references

0 references

0 references

1 reference

haloperidol (English)

19 November 2016

DrugBank ID

DB00502

1 reference

Human Metabolome Database ID

HMDB0014645

2 references

based on heuristic

inferred from InChIKey

2 references

haloperidol (English)

19 November 2016

MedlinePlus drug identifier

a682180

oral administration

0 references

a615023

intramuscular injection

0 references

NDF-RT ID

N0000146461

1 reference

haloperidol (English)

19 November 2016

0 references

1 reference

1 reference

haloperidol (English)

3 October 2016

1 reference

California Proposition 65 list of chemicals

haloperidol (English)

3 October 2016

0 references

1 reference

6 January 2020

https://oehha.ca.gov/chemicals/haloperidol

electronic Essential Medicines List medicine ID

25

1 reference

https://list.essentialmeds.org/medicines/25

eEML - Electronic Essential Medicines List (English)

Encyclopædia Britannica Online ID

23 October 2021

Elhuyar ZTH ID

024912

0 references

science/haloperidol

subject named as

haloperidol

0 references

1 reference

28 October 2013

Gran Enciclopèdia Catalana ID

haloperidol

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0113487

0 references

J-GLOBAL ID

200907040481182796

0 references

Microsoft Academic ID

2780948584

0 references

NALT ID

10297

0 references

NCI Drug Dictionary ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

ScienceDirect topic ID

biochemistry-genetics-and-molecular-biology/haloperidol

0 references

Store medisinske leksikon ID

haloperidol

0 references

UK Parliament thesaurus ID

540051

subject named as

Haloperidol

0 references

UMLS CUI

C0018546

1 reference

haloperidol (English)

19 November 2016

WikiProjectMed ID

Haloperidol

0 references

WordNet 3.1 Synset ID

03485269-n

1 reference